Page last updated: 2024-08-24

diphenylcyclopropenone and HIV Coinfection

diphenylcyclopropenone has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holzer, AM; Leonard, LK; Levis, WR1
Levis, WR1

Trials

1 trial(s) available for diphenylcyclopropenone and HIV Coinfection

ArticleYear
Topical diphenylcyclopropenone as a measure of immune competence in HIV-seropositive subjects.
    Journal of drugs in dermatology : JDD, 2006, Volume: 5, Issue:9

    Topics: Administration, Cutaneous; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclopropanes; HIV Infections; HIV Seropositivity; Humans; Immunocompromised Host; Patch Tests; Photosensitizing Agents; Predictive Value of Tests; Viral Load

2006

Other Studies

1 other study(ies) available for diphenylcyclopropenone and HIV Coinfection

ArticleYear
Evaluation of delayed-type hypersensitivity in patients with suspected immunodeficiency.
    The American journal of medicine, 2008, Volume: 121, Issue:3

    Topics: Cyclopropanes; Dermatitis, Allergic Contact; HIV Infections; Humans; Hypersensitivity, Delayed; Immunocompetence; Skin Tests

2008